spacer
home > pmps > summer 2002 > nutraceuticals production standards
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Nutraceuticals Production Standards

In many aspects, nutraceutical products fall halfway between pharmaceuticals and food. They are very similar to medical products in terms of their formulation and presentation, but to all intents and purposes they belong to the food goods category.

There are several standards that need to be observed if one wants to maintain quality production of these products. From a quick perusal of the list of standards that govern this sector, one fact immediately emerges: there is no specific set of rules - such as the Good Manufacturing Practices (GMP) for pharmaceuticals - specifically drawn up for the production, packing and preservation of nutraceuticals.

In fact, when it comes to the production and control of nutraceuticals, operators in this field must adopt the 'horizontal' rules applying to the food sector (in their widest sense), plus the HACCP self-control and monitoring rules regarding the hygiene aspects of processing and - on a voluntary basis - the ISO quality management systems, though there are no sector-specific systems.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Cesare Dognini, Quality Assurance Manager at Fine Foods NTM S.p.A. Dr Cesare Dognini graduated in Pharmaceutical Chemistry and Technology. He has been working in pharmaceuticals for more than 14 years in production, quality control and quality assurance. Cesare is currently the Quality Assurance Manager at Fine Foods NTM S.p.A., an Italian contract manufacturer of pharmaceutical and nutraceutical products.
spacer
Dr Cesare Dognini
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed

Burgdorf – Teva Pharmaceutical Industries Ltd. (Teva), a global leader in generic medicines with innovative treatments in select areas, including central nervous system, pain and respiratory, launches its drug product AJOVY® in the pre-filled YpsoMate 2.25 autoinjector from Ypsomed. AJOVY® is used for the preventive treatment of migraine in adults. The collaboration with Teva marks the first commercial market entry of Ypsomed’s larger 2.25 ml autoinjector YpsoMate 2.25.
More info >>

White Papers

Finding the Right End-to-End Safety Solution for Your Needs

Bioclinica

With upcoming changes, including the implementation of the International Conference on Harmonisation (ICH) E2B(R3) Electronic Transmission of Individual Case Safety Report and Identification of Medicinal Products (IDMP) standards, the current state of safety reporting can be confusing. Your existing safety system may not be flexible enough to accommodate these changing regulations, which are still moving targets regarding the details needed for a comprehensive solution with the right level of processes, company-to-company integrations and finalized regional rules.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement